
The current and former CEOs of FTX are to testify before a Congressional committee.
FTX Group founder and former CEO Sam Bankman-Fried and current FTX Group CEO John J. Ray III are to be witnesses at a Tuesday (Dec. 13) hearing called “Investigating the Collapse of FTX, Part I,” the U.S. House Committee on Financial Services said in a Dec. 9 media advisory emailed to PYMNTS.
Led by Chairwoman Maxine Waters, the hybrid hearing will have a virtual option so that members and witnesses can participate remotely, and it will be livestreamed.
The hearing is scheduled to start at 10 a.m. ET on Dec. 13, but the media advisory suggested checking the committee’s calendar.
Related: DOJ Wants An Independent Examiner To Look Into FTX
As PYMNTS reported Friday (Dec. 9), Bankman-Fried tweeted to Waters — with his replies off — that “As the committee still thinks it would be useful, I am willing to testify on the 13th.”
Witnesses invited to appear before Congressional committees traditionally make themselves available voluntarily. Bankman-Fried’s change of heart comes less than a week after he was “not sure” whether he would testify, again sent out via Twitter, saying he needed time to “finish learning and reviewing what happened.”
Presumably, he will appear virtually as his whereabouts remain unknown.
Meanwhile, Ray — who was appointed CEO of FTX in November as part of the firm’s bankruptcy proceedings — and bankruptcy lawyers reportedly met with prosecutors from the U.S. Attorney’s Office for the Southern District of New York, Bloomberg reported Thursday (Dec. 9).
The report said that the meeting details were unavailable but that the prosecutors are investigating allegations that FTX misused customers’ funds and lost billions of dollars.
Featured News
Federal Reserve Greenlights Capital One’s $35.3 Billion Acquisition of Discover
Apr 18, 2025 by
CPI
Google to Appeal Partial Ruling in DOJ Antitrust Case
Apr 18, 2025 by
CPI
Indian Ad Agencies Warned Against WhatsApp Discussions After Antitrust Raids
Apr 17, 2025 by
CPI
US Court Ruling Against Google Spurs Fresh Antitrust Tensions in Europe
Apr 17, 2025 by
CPI
AstraZeneca Accused of Stifling Biosimilar Competition for Rare Disease Drug
Apr 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Airline Industry
Apr 10, 2025 by
CPI
Boosting Competition in International Aviation
Apr 10, 2025 by
Jeffrey N. Shane
Reshaping Competition Policy for the U.S. Airline Industry
Apr 10, 2025 by
Diana L. Moss
Algorithmic Collusion in the Skies: The Role of AI in Shaping Airline Competition
Apr 10, 2025 by
Qi Ge, Myongjin Kim & Nicholas Rupp
Competition in U.S. Airline Markets: Major Developments and Economic Insights
Apr 10, 2025 by
Germán Bet